130 related articles for article (PubMed ID: 37994264)
1. Molecular characterization of the craniosynostosis-associated interleukin-11 receptor variants p.T306_S308dup and p.E364_V368del.
Kespohl B; Hegele AL; Düsterhöft S; Bakker H; Buettner FFR; Hartig R; Lokau J; Garbers C
FEBS J; 2024 Apr; 291(8):1667-1683. PubMed ID: 37994264
[TBL] [Abstract][Full Text] [Related]
2. The length of the interleukin-11 receptor stalk determines its capacity for classic signaling.
Lokau J; Garbers C
J Biol Chem; 2018 Apr; 293(17):6398-6409. PubMed ID: 29523682
[TBL] [Abstract][Full Text] [Related]
3. Mutations in Craniosynostosis Patients Cause Defective Interleukin-11 Receptor Maturation and Drive Craniosynostosis-like Disease in Mice.
Agthe M; Brügge J; Garbers Y; Wandel M; Kespohl B; Arnold P; Flynn CM; Lokau J; Aparicio-Siegmund S; Bretscher C; Rose-John S; Waetzig GH; Putoczki T; Grötzinger J; Garbers C
Cell Rep; 2018 Oct; 25(1):10-18.e5. PubMed ID: 30282020
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic control of Interleukin-11 and Interleukin-6 biology.
Lokau J; Agthe M; Flynn CM; Garbers C
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2105-2117. PubMed ID: 28630024
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-11 (IL-11) receptor cleavage by the rhomboid protease RHBDL2 induces IL-11 trans-signaling.
Koch L; Kespohl B; Agthe M; Schumertl T; Düsterhöft S; Lemberg MK; Lokau J; Garbers C
FASEB J; 2021 Mar; 35(3):e21380. PubMed ID: 33566379
[TBL] [Abstract][Full Text] [Related]
6. The role of proteolysis in interleukin-11 signaling.
Lokau J; Kespohl B; Kirschke S; Garbers C
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119135. PubMed ID: 34624437
[TBL] [Abstract][Full Text] [Related]
7. Cleavage of the Interleukin-11 receptor induces processing of its C-terminal fragments by the gamma-secretase and the proteasome.
Lokau J; Flynn CM; Garbers C
Biochem Biophys Res Commun; 2017 Sep; 491(2):296-302. PubMed ID: 28735867
[TBL] [Abstract][Full Text] [Related]
8. Generation of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during Inflammation.
Lokau J; Agthe M; Garbers C
Mediators Inflamm; 2016; 2016():1785021. PubMed ID: 27493449
[TBL] [Abstract][Full Text] [Related]
9. Two N-Linked Glycans Differentially Control Maturation, Trafficking and Proteolysis, but not Activity of the IL-11 Receptor.
Agthe M; Garbers Y; Grötzinger J; Garbers C
Cell Physiol Biochem; 2018; 45(5):2071-2085. PubMed ID: 29533934
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic Cleavage Governs Interleukin-11 Trans-signaling.
Lokau J; Nitz R; Agthe M; Monhasery N; Aparicio-Siegmund S; Schumacher N; Wolf J; Möller-Hackbarth K; Waetzig GH; Grötzinger J; Müller-Newen G; Rose-John S; Scheller J; Garbers C
Cell Rep; 2016 Feb; 14(7):1761-1773. PubMed ID: 26876177
[TBL] [Abstract][Full Text] [Related]
11. Recombinant soluble interleukin-11 (IL-11) receptor alpha-chain can act as an IL-11 antagonist.
Curtis DJ; Hilton DJ; Roberts B; Murray L; Nicola N; Begley CG
Blood; 1997 Dec; 90(11):4403-12. PubMed ID: 9373251
[TBL] [Abstract][Full Text] [Related]
12. Modular organization of Interleukin-6 and Interleukin-11 α-receptors.
Nitz R; Lokau J; Aparicio-Siegmund S; Scheller J; Garbers C
Biochimie; 2015 Dec; 119():175-82. PubMed ID: 26551279
[TBL] [Abstract][Full Text] [Related]
13. Differences in Shedding of the Interleukin-11 Receptor by the Proteases ADAM9, ADAM10, ADAM17, Meprin α, Meprin β and MT1-MMP.
Sammel M; Peters F; Lokau J; Scharfenberg F; Werny L; Linder S; Garbers C; Rose-John S; Becker-Pauly C
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357561
[TBL] [Abstract][Full Text] [Related]
14. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
[TBL] [Abstract][Full Text] [Related]
15. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-11-driven gastric tumourigenesis is independent of trans-signalling.
Balic JJ; Garbers C; Rose-John S; Yu L; Jenkins BJ
Cytokine; 2017 Apr; 92():118-123. PubMed ID: 28160627
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-11 signals through the formation of a hexameric receptor complex.
Barton VA; Hall MA; Hudson KR; Heath JK
J Biol Chem; 2000 Nov; 275(46):36197-203. PubMed ID: 10948192
[TBL] [Abstract][Full Text] [Related]
18. The interleukin-11 receptor variant p.W307R results in craniosynostosis in humans.
Ahmad I; Lokau J; Kespohl B; Malik NA; Baig SM; Hartig R; Behme D; Schwab R; Altmüller J; Jameel M; Mucha S; Thiele H; Tariq M; Nürnberg P; Erdmann J; Garbers C
Sci Rep; 2023 Aug; 13(1):13479. PubMed ID: 37596289
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of IL-6 trans-signaling by a miniaturized, optimized chimeric soluble gp130 inhibits T
Heise D; Derrac Soria A; Hansen S; Dambietz C; Akbarzadeh M; Berg AF; Waetzig GH; Jones SA; Dvorsky R; Ahmadian MR; Scheller J; Moll JM
Sci Signal; 2021 Aug; 14(696):. PubMed ID: 34404751
[TBL] [Abstract][Full Text] [Related]
20. Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor.
Karow J; Hudson KR; Hall MA; Vernallis AB; Taylor JA; Gossler A; Heath JK
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):489-95. PubMed ID: 8809037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]